NASDAQ NMS - GLOBAL MARKET · ATRA
+3.41% · +$0.3200 · Vol 27.1K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Atara Biotherapeutics Inc

Atara Biotherapeutics Inc

Biotechnology
$9.70
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ATRA
Atara Biotherapeutics Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

81/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ATRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ATRA catalysts
About Atara Biotherapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2014
Employees
10
Country
US

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.46
Day high
$9.89
Day low
$9.15
Previous close
$9.38
52W high
$18.09
-46.38% from high
52W low
$4.18
40% of range
Market cap
$97.4M
P/E
2.61×
EPS
$-0.7400
Beta
0.33
Shares out
10M
Volume
27.1K
0.43× rel vol
Avg volume
62.4K
VWAP
$9.57
Price history computed in-house
1W
+16.03%
1M
+22.78%
3M
+0.94%
1Y
-21.39%
YTD
-46.38%
SMA 50 $9.29 · above
SMA 200 $8.97 · above
52W position 40%

ATRA overview

Veridion Score
81
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ATRA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ATRA Form 4 filings
Public disclosures

Congress activity in ATRA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ATRA in the cached public ledger.

Federal contracts

ATRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ATRA in this window.
Lobbying spend

ATRA lobbying filings, year to date.

Registered lobbying filings matched to Atara Biotherapeutics Inc.

$10.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$10.0K
ATARA BIOTHERAPEUTICS INC.

JEFFREY J. KIMBELL & ASSOCIATES, INC.

Jul 20, 2026
Loading news for ATRA
Analyst ratings
Sovereign unlock shows live analyst consensus for ATRA.
Options
Sovereign unlock shows live options positioning for ATRA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.